YTEN - Yield10 Bioscience, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.6100
+0.0048 (+0.79%)
As of 1:54PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.6052
Open0.6354
Bid0.6100 x 1200
Ask0.6200 x 1000
Day's Range0.6100 - 0.6467
52 Week Range0.5900 - 1.7700
Volume51,565
Avg. Volume164,678
Market Cap7.637M
Beta (3Y Monthly)1.57
PE Ratio (TTM)N/A
EPS (TTM)-0.8010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.25
Trade prices are not sourced from all markets
  • Do Insiders Own Shares In Yield10 Bioscience, Inc. (NASDAQ:YTEN)?
    Simply Wall St.

    Do Insiders Own Shares In Yield10 Bioscience, Inc. (NASDAQ:YTEN)?

    A look at the shareholders of Yield10 Bioscience, Inc. (NASDAQ:YTEN) can tell us which group is most powerful...

  • GlobeNewswire

    Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that it has expanded its non-exclusive research license with Bayer for soybean crop research to include a new discovery related to its C3004 yield trait gene. Yield10 is developing C3003 and C3004 as novel yield trait genes to increase seed yield in commercially important crops.  Under the amended research license, Bayer will have access to these new developments from Yield10’s C3004 program and new advanced technology related to the C3004 trait and its potential to increase seed yield.

  • GlobeNewswire

    Yield10 Bioscience Announces Second Quarter 2019 Financial Results

    WOBURN, Mass., Aug. 12, 2019 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for.

  • ACCESSWIRE

    Yield10 Bioscience, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Yield10 Bioscience, Inc. (NASDAQ: YTEN ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 12, 2019 at 4:30 ...

  • GlobeNewswire

    Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C4001

    The Notice of Allowance relates to Yield10’s U.S. patent application US15/897,958 titled “Transcriptional Regulation for Improved Plant Productivity.” This patent application describes the C4001 yield trait, which is based on the discovery of novel transcription factor genes in plants where an increase in the productivity of photosynthesis results in significant increases in biomass yield and stress tolerance.

  • GlobeNewswire

    Yield10 Bioscience to Announce Second Quarter 2019 Financial Results and Host a Conference Call on Monday, August 12, 2019

    WOBURN, Mass., Aug. 06, 2019 -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for.

  • GlobeNewswire

    Yield10 Bioscience Granted U.S. Patent Covering Crop Yield Trait C3003

    The U.S. patent 10,337,024 is entitled, “Plants with enhanced photosynthesis and methods of manufacture thereof.” Yield10 is the exclusive licensee of this intellectual property from The University of Massachusetts. C3003 is believed to play a role in carbon capture and directing carbon to seed. Under research licenses with Yield10, two major seed companies are progressing evaluation of C3003 in soybean and forage sorghum, respectively.

  • GlobeNewswire

    Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the Plant Biology 2019 Conference

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that Kristi Snell, Ph.D., Yield10’s chief science officer, will present at the Plant Biology 2019 conference, the annual meeting of the American Society of Plant Biologists (ASPB).  The conference is being held August 3-7 in San Jose, California. At the Plant Biology 2019 Conference, Dr. Snell will serve as Chair for “Concurrent Symposium 20: Edited for Content” session, which is scheduled from 3:15 pm to 5:00 pm local time on Monday, August 5. Dr. Snell will moderate this session and present a talk titled “Genome editing to increase seed yield and oil content.” In the presentation, Dr. Snell will discuss strategies the Yield10 team has employed to identify and edit novel gene targets using CRISPR genome editing to improve seed yield and oil content in oilseed crops.

  • How Many Yield10 Bioscience, Inc. (NASDAQ:YTEN) Shares Did Insiders Buy, In The Last Year?
    Simply Wall St.

    How Many Yield10 Bioscience, Inc. (NASDAQ:YTEN) Shares Did Insiders Buy, In The Last Year?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

  • GlobeNewswire

    Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Unique Aspects of the Company’s GRAIN Technology Platform to Identify Novel Traits for Crops at the 3rd Precision CRISPR & NBT AgBio Congress

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that Kristi Snell, Ph.D., Yield10’s chief science officer, will present at the 3rd Precision CRISPR & NBT AgBio Congress which is being held June 24-26 in San Diego, California. Dr. Snell will present a talk entitled “Exploring Novel Approaches for Gene Selection and Trait Validation in Crops.” The presentation will be part of the “Novel Approaches Beyond Genomics to Improve Yield, Productivity and Resistance” session which is scheduled from 11:10 am to 12:40 pm local time on June 26. In her presentation, Dr. Snell will discuss the components of Yield10’s proprietary GRAIN (Gene Ranking Artificial Intelligence Network) platform, highlighting recent advancements.

  • GlobeNewswire

    Yield10 Bioscience Files U.S. Patent Application Covering New Technology Enabling Low-cost Production of PHA-based Biomaterials in Camelina

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that the Company has filed a U.S. Patent application for new technology enabling low-cost production of PHA-based (“polyhydroxyalkanoate”) biomaterials in Camelina sativa, an oilseed crop. PHA-based biomaterials are of significant interest for their use in water treatment to remove nitrogen and phosphates, and as a biodegradable replacement for petroleum plastics in a range of applications. The new Yield10 patent application describes a discovery around maintaining the viability and vigor of Camelina seed containing high levels of PHA biopolymer.

  • GlobeNewswire

    Yield10 Bioscience, Inc. to Present at the Ladenburg Thalmann Technology Expo 2019 on May 30, 2019

    WOBURN, Mass., May 28, 2019 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for.

  • GlobeNewswire

    Yield10 Bioscience Announces First Quarter 2019 Financial Results

    WOBURN, Mass., May 09, 2019 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for.

  • GlobeNewswire

    Yield10 Bioscience Signs Exclusive Worldwide License with University of Missouri for Advanced Technology Used to Boost Oil Content in Crops

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that it has signed an exclusive worldwide license from the University of Missouri (MU) for a novel, advanced technology to boost oil content in crops. The license expands Yield10’s intellectual property portfolio around technologies for increasing oil content in oilseed crops. This new gene target, designated C3012 by Yield10, is consistent with the Company’s focus on using CRISPR-Cas/9 genome-editing to increase seed oil content, the primary economic value driver in these crops.

  • American City Business Journals

    These are the highest paid tech CEOs in Massachusetts

    The Boston Business Journal’s ranking of the highest paid tech CEOs is a look at 25 chief executives' total compensation in Massachusetts companies, based on information from proxy statements filed with the Securities and Exchange Commission in spring of this year.

  • GlobeNewswire

    Yield10 Bioscience to Announce First Quarter 2019 Financial Results and Host a Conference Call on Thursday, May 9, 2019

    Yield10 Bioscience, Inc. (YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, announced today that the Company will report its first quarter 2019 financial results and provide a corporate update on Thursday, May 9, 2019. International callers should call +1-201-689-8354. The call will also be available through a live webcast, and will reference a slide deck which may be accessed through the investor relations section of the Company’s website at www.yield10bio.com.

  • GlobeNewswire

    Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C3003

    The Notice of Allowance relates to U.S. patent application No. 2016/032,6541 entitled “Plants with enhanced photosynthesis and methods of manufacture thereof.” Yield10 is the exclusive licensee of this intellectual property from The University of Massachusetts. The C3003 yield trait is based on a transporter gene derived from algae that can be used to increase seed yield in plants.

  • Woburn agri-biotech Yield10 needs to secure extra funds to continue operations
    American City Business Journals

    Woburn agri-biotech Yield10 needs to secure extra funds to continue operations

    Woburn-based agricultural bioscience company Yield10 needs to secure funding to make it through the year, according to the company’s public filings, and it’s considering different ways to bring in additional capital, the CEO told the Boston Business Journal.

  • The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail
    Zacks

    The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail

    The Zacks Analyst Blog Highlights: MGP Ingredients, Medifast, Ubiquiti Networks, Yield10 Bioscience and Otter Tail

  • Global Economic Growth Concerns Resurface: 5 Safe Picks
    Zacks

    Global Economic Growth Concerns Resurface: 5 Safe Picks

    Concerns over slowing global growth have contributed to this uncertainty and dented investors' confidence to some extent.

  • GlobeNewswire

    Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019

    Dr. Peoples’ presentation is titled “The Yield10 Trait Factory: Deploying Knowledge Gained from Industrial Biotech with Genome-editing to Increase Crop Yield” and will take place on the ABLC Advanced Nutrition & Bioeconomy Feedstocks and Supply Chain track in a panel entitled “Advanced Yields through Technology” on Wednesday April 3, 2019 at 12:40 p.m. Eastern Time. Dr. Peoples will describe the approaches Yield10 is taking to increase seed yield, oil content and biomass in crops.

  • GuruFocus.com

    Yield10 Bioscience Inc (YTEN) Files 10-K for the Fiscal Year Ended on December 31, 2018

    Yield10 Bioscience Inc, formerly known as Metabolix Inc is an agricultural bioscience company. Yield10 Bioscience Inc had annual average EBITDA growth of 54.90% over the past five years. Warning! GuruFocus has detected 5 Warning Signs with YTEN.

  • GlobeNewswire

    Yield10 Bioscience Announces Fourth Quarter and Full Year 2018 Financial Results

    WOBURN, Mass., March 25, 2019 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for.

  • GlobeNewswire

    Yield10 Bioscience to Present at the Spring Investor Summit on April 2, 2019

    Yield10 Bioscience, Inc. (YTEN) today announced that Oliver Peoples, Ph.D., president and chief executive officer of Yield10 will be a featured presenter at the Spring Investor Summit on Tuesday, April 2, 2019 at 10:30 a.m. EDT. Dr. Peoples will provide an overview of the Company’s business model and growth strategy and will be available for one-on-one meetings. A live webcast of the corporate presentation will be available on the Company's website at  www.yield10bio.com.  A replay of the presentation will be available for 90 days.